AERIE PHARMACEUTICALS INC Quarterly Depreciation in USD from Q1 2013 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from Q1 2013 to Q1 2022.
  • Aerie Pharmaceuticals Inc Depreciation for the quarter ending March 31, 2022 was $1.6M, a 7.01% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Depreciation for 2021 was $6.4M, a 0.52% increase from 2020.
  • Aerie Pharmaceuticals Inc annual Depreciation for 2020 was $6.37M, a 23.9% increase from 2019.
  • Aerie Pharmaceuticals Inc annual Depreciation for 2019 was $5.14M, a 110% increase from 2018.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.6M +$105K +7.01% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q1 2021 $1.5M -$92K -5.78% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $1.59M +$1.03M +182% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $564K +$77K +15.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $487K +$196K +67.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $291K +$68K +30.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 $223K +$199K +829% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q1 2015 $24K +$9K +60% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q1 2014 $15K $0 0% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 $15K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.